Filing Flows › Stemtech (STEK) › Q3 2025
Stemtech (STEK) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 19, 2025
Stemtech (STEK) reported revenue of $852K for the third quarter 2025 (Q3 2025), -17% from a year earlier and +22% from the quarter before. Operating margin was -39.8%, net loss $813K (95.3% of revenue).
Stemtech, Q3 2025: revenue $852K (-17% year over year), operating margin -39.8%, net loss $813K, operating cash flow $25K. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $852K | +22% | -17% |
| Operating profit | −$339K | — | — |
| Net earnings | −$813K | — | — |
| Operating cash flow | $25K | -67% | — |
What changed
Revenue was $852K in Q3 2025, down 17% year over year and up 22% from the previous quarter.
Gross margin was 80.1%, up 16.9 points from a year earlier. Operating costs exceeded revenue by $339K, an operating margin of -39.8%. Operating expenses fell 25% while revenue fell 17%. The quarter ended with a net loss of $813K, wider than the previous quarter's $296K loss. Minority interests bore $3K of it: to shareholders the quarter was a loss of $809K. Net interest and other expense of $473K was the main reason.
Operating cash flow was $25K. Non-cash charges added back $42K of depreciation and amortization and $111K of share-based compensation. Working capital and other items added $685K.
Questions
What was Stemtech's revenue in the third quarter 2025?
Stemtech (STEK) reported revenue of $852K for the third quarter 2025 (Q3 2025), -17% from a year earlier and +22% from the quarter before.
Was Stemtech profitable in the third quarter 2025?
Operating loss was $339K (-39.8% of revenue) and net loss $813K.
Source: Stemtech 10-Q on SEC EDGAR.